行情

ITMR

ITMR

Itamar Medical Ltd
NASDAQ

实时行情|Nasdaq Last Sale

14.50
-0.48
-3.20%
已收盘, 16:00 01/27 EST
开盘
14.30
昨收
14.98
最高
14.50
最低
14.09
成交量
6,803
成交额
--
52周最高
15.98
52周最低
7.66
市值
48.62亿
市盈率(TTM)
-1028.3688
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ITMR 新闻

  • Acceleron肺高压药物试验达到主要目标 股价暴涨79%
  • 新浪财经.4小时前
  • 英国超市巨头承诺投10亿英镑 到2040年实现零排放
  • 新浪财经.5小时前
  • 韩国政府:将全力以赴抗击疫情并稳定金融市场
  • 新浪财经.5小时前
  • 美国父母的儿童早教支出每年高达420亿美元
  • 新浪财经.5小时前

更多

所属板块

先进医疗设备和技术
-1.95%
医疗设备和用品
-1.02%

热门股票

名称
价格
涨跌幅

ITMR 简况

Itamar Medical Ltd. is an Israel-based medical signal company engaged in the development of a proprietary non-invasive window to the autonomic nervous system, the peripheral arterial tone (PAT) signal, which is change in arterial volume pulsation f the various indices in peripheral arterial. PAT-based products can provide an early-stage detection of disease, facilitate patient follow-up, and help to improve patient care while reducing the overall cost of healthcare. Two devices based on PAT technology have been cleared for sale: Endo-PAT2000 is a non-invasive method to evaluate endothelial function, which is available for sale as a research package only, and Watch-PAT100 is an unattended home care diagnostic device for the detection of sleep-related breathing disorders.
展开

Webull提供Itamar Medical Ltd的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。